Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2026.10.16

NAV

11,520KRW

+0.52상승 (-%)

Market Price per share (KRW)

11,490KRW

+170상승 (1.5%)

※ t-1 last price

trading volume

16,770shares

AUM

KRW 20.7billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2026.10.16
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 20,736,365,186
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,490
※ t-1 last price
11,520 16,770
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
20,736,365,186 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,490
※ t-1 last price
11,520
Trading Volume (shares)
16,770
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2026-10-16
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB03375-3103(26-3) 23.91
2 RISE KTB 20.78
3 KTB03500-2906(26-5) 14.72
4 KTB02750-2812(25-10) 14.50
5 RISE HealthCare 9.48
6 Celltrion 2.09
7 KTB3 F 202612 1.99
8 SAMSUNG BIOLOGICS 1.87
9 Alteogen 1.53
10 HLB 1.19

proportion by sectors

*The proportion of investment stocks

Update : 2026.10.16
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-06-09 2026-06-11 50
2025-12-09 2025-12-11 50
2025-06-09 2025-06-11 50
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2026-10-16

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 0.24 -0.15 -10.56 -5.70 9.78 -9.42 20.98
Benchmark Index 0.20 0.17 -9.62 -4.18 14.25 -7.75 30.40
Outperformance 0.03 -0.32 -0.95 -1.53 -4.48 -1.67 -9.42

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.10.16 11,490 1.501상승 11,519.68 1.448상승 10,371.64
2026.10.15 11,320 -0.527하락 11,355.24 -0.284하락 10,363.71
2026.10.14 11,380 -0.350하락 11,387.59 -0.370하락 10,360.73
2026.10.13 11,420 -0.174하락 11,429.9 -0.282하락 10,361.04
2026.10.12 11,440 -0.218하락 11,462.29 -0.558하락 10,341.44
2026.10.08 11,465 -0.993하락 11,525.03 -1.063하락 10,325.33
2026.10.07 11,580 -0.215하락 11,648.86 -0.208하락 10,332.56
2026.10.06 11,605 0.476상승 11,673.23 0.742상승 10,335.21
2026.10.02 11,550 -0.559하락 11,585.58 -0.213하락 10,327
2026.10.01 11,615 1.574상승 11,610.33 0.958상승 10,310.15
2026.09.30 11,435 0.263상승 11,500.09 0.239상승 10,305.33
2026.09.29 11,405 -0.436하락 11,472.63 0.066상승 10,290
2026.09.28 11,455 0.482상승 11,465.05 0.304상승 10,287.23
2026.09.23 11,400 0.396상승 11,428.04 0.026상승 10,304.71
2026.09.22 11,355 -0.569하락 11,425.04 -0.320하락 10,294.63
2026.09.21 11,420 0.263상승 11,461.73 0.063상승 10,291.72
2026.09.18 11,390 -0.219하락 11,453.3 -0.337하락 10,292.18

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 KTB03375-3103(26-3) KR103503GG37 555,555,555 23.91 543,022,777
2 RISE KTB KR7114100001 4,422 20.78 471,849,510
3 KTB03500-2906(26-5) KR103501GG62 333,333,333 14.72 334,293,666
4 KTB02750-2812(25-10) KR103501GFC3 333,333,333 14.5 329,221,333
5 RISE HealthCare KR7253280002 19,141 9.48 215,336,250
6 Celltrion KR7068270008 261 2.09 47,528,100
7 KTB3 F 202612 KR4A656C0009 0.44 1.99 45,298,000
8 SAMSUNG BIOLOGICS KR7207940008 34 1.87 42,398,000
9 Alteogen KR7196170005 163 1.53 34,800,500
10 HLB KR7028300002 663 1.19 27,017,250
11 Yuhan KR7000100008 310 1.04 23,684,000
12 원화예금 KRD010010001 19,119,840 0.84 19,119,840
13 SKBP KR7326030004 224 0.68 15,545,600
14 SCD KR7000250001 78 0.66 15,030,600
15 HanmiPharm KR7128940004 35 0.59 13,510,000
16 SAMSUNG EPIS HOLDINGS KR70126Z0002 37 0.5 11,285,000
17 PharmaResearch KR7214450009 37 0.42 9,564,500
18 ABL Bio KR7298380007 237 0.42 9,610,350
19 LCB KR7141080002 148 0.41 9,294,400
20 HANALL BIOPHARMA KR7009420001 197 0.35 8,057,300
21 L&C BIO KR7290650001 116 0.29 6,577,200
22 SEEGENE KR7096530001 179 0.28 6,435,050
23 ST Pharm KR7237690003 73 0.27 6,117,400
24 SKBS KR7302440003 148 0.23 5,231,800
25 Hanmi Science KR7008930000 114 0.23 5,181,300
26 Hugel KR7145020004 30 0.22 5,055,000
27 Lunit KR7328130000 392 0.19 4,327,680
28 CLASSYS KR7214150005 149 0.18 4,060,250
29 Celltrionph KR7068760008 114 0.18 4,166,700
30 GC Biopharma Corp. KR7006280002 31 0.17 3,875,000
31 Pharmicell KR7005690003 313 0.14 3,245,810
32 DongKook Pharm KR7086450004 132 0.14 3,260,400
33 CHONGKUNDANG KR7185750007 44 0.13 2,926,000
34 HK inno.N KR7195940002 79 0.12 2,749,200
35 DAEWOONG PHARM KR7069620003 25 0.12 2,625,000
36 CHA Biotech KR7085660009 335 0.11 2,468,950
37 HLBPHARMA KR7047920004 207 0.1 2,177,640
38 ShinpoongPharm KR7019170000 222 0.09 2,042,400
39 MedyTox KR7086900008 31 0.09 2,005,700
40 i-SENS KR7099190001 122 0.08 1,915,400
41 JWPHARMA KR7001060003 75 0.08 1,830,000
42 ORUM KR7475830006 103 0.07 1,650,060
43 ILDONG PHARM KR7249420001 118 0.07 1,517,480
44 EuBio KR7206650004 174 0.06 1,353,720
45 DENTIUM KR7145720009 37 0.06 1,387,500
46 T&L KR7340570001 51 0.06 1,277,550
47 WONTECH KR7336570007 241 0.05 1,053,170
48 GC Corp. KR7005250006 121 0.05 1,102,310
49 CUREXO KR7060280005 163 0.05 1,180,120
50 Binex KR7053030003 161 0.04 924,140
51 Huons Global KR7084110006 30 0.03 639,000
52 KLS KR7102940004 42 0.02 519,960
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.